Author: John

on

 

No matter the reason, going to court and dealing with legal proceedings can be a headache. It can also feel like a heavy burden especially when courts start issuing requirements such as court ordered drug or alcohol tests. Whether you’re on probation or dealing with child custody, Accredited Drug Testing can make your court ordered drug testing needs painless.

Child Custody Court-Ordered Drug Tests

 To protect children, it’s not uncommon for legal parties to seek court-ordered drug tests in cases involving child custody issues. Test results are often used to prove, or disprove, an individual’s fitness as a parent or may be considered to determine initial custody agreements. Other child custody court-ordered drug tests can also be part of an ongoing random drug testing program. Spouses may be requested to submit to one-time-only drug tests, random drug testing over a period of time, or testing prior to visitation rights.

Child custody proceedings can be stressful especially when there are drug or alcohol related testing requirements. Accredited Drug Testing is here to help alleviate that stress with fast, easy drug testing options for all of your child custody needs.

Customized Court-Ordered Drug Testing Requirements

If you’re on probation or going through any form of litigation, depending on your case, the court may require specific drug and alcohol testing requirements. Some drug or alcohol testing requirements may include hair follicle testing for alcohol, or tests that screen for specific drugs with longer detection periods. For example, the court may require a screening that detects drug use during the previous 90 days.

Court-ordered drug tests will also often carry with them stipulations regarding payment for testing services. One party may be responsible for covering the drug-testing expenses, costs may be divided between multiple parties, or a mutual agreement may be made. Whatever the case may be, or no matter the type of screening requirements, Accredited Drug Testing centers are dedicated to accommodating most arrangements.

Court-ordered drug tests should contain detailed instructions specifying the type of test to be administered and the drugs that should be screened for. If sample collection needs to be witnessed to prevent potential tampering or substitution, those specifications will be stated in the court order.

We Specialize in:

  • Court Ordered Drug and Alcohol Testing
  • Child Custody Court Ordered Drug Testing
  • Customized Drug Testing
  • Exceptional Customer Service

Accredited Drug Testing, Inc. provides court ordered drug testing which includes drug and alcohol tests that are utilized for a wide variety of court ordered proceedings including probation and other types of government required tests.

Test results can be submitted for a wide variety of court-ordered proceedings including probation hearings, child custody cases, litigation, and all manner of government required tests.

Accredited Drug Testing is able to meet and exceed your needs, for more information regarding our Court Ordered Drug Tests or to schedule an appointment, Call Today 800-221-4291

on

 

 

Investigators revealed that all three of the individuals involved in a fatal Amtrak crash near Philadelphia last April 2016 tested positive for drug use.  One of the individuals was the train’s engineer and two members of a railway work crew who both were killed, according to federal investigators.

According to investigators, Alexander Hunter, 48 was the trains engineer and survived the crash, had used marijuana.   Testing also showed that Joseph Carter (61), a backhoe operator, had used cocaine and the supervisor of the work crew, Peter John Adamovich, 59, had used oxycodone, according to test results.

The National Transportation Safety Board stated that both Carter and Adamovich were killed when a southbound passenger train traveling at 106 miles per hour struck the backhoe working on an adjacent track.

The trio of positive drug tests were part of an alarming increase of drug use by railroad workers that was documented last year by the Federal Railroad Administration (FRA).

The FRA reported that nearly 5 percent of workers involved in accidents in 2016 were found to have used illegal drugs.  The FRA reacted to the Chester crash by requiring that track-bed maintenance workers be included in the extensive drug testing program that has been in place for train crew members for more than 30 years.

The fatal collision between Amtrak’s Palmetto train, with 330 passengers and seven crew members took place early on a Sunday morning and 40 people on board were taken to hospitals with minor injuries.

Railroad workers are amongst the most heavily drug-tested employees in the U.S.  They are required to submit to pre-employment drug screenings, random drug testing and post-accident testing.

In the last several years’ heroin and illegal opioid use has increased dramatically in the general population and it was evident that use of those and other drugs was on the rise in the railroad industry.

Since 2009 there had been no considerable increase in positive test results from the approximate 50,000 random tests conducted each year.  However, in 2015, random screenings of railway workers which includes engineers, train crew and dispatchers increased by 43 percent.

on

 

 

The American Medical Association’s (AMA) annual State Legislative Strategy Conference held in early January in Amelia Island, Fla., determined several areas of focus to address with state legislators during 2017 which include the opioid epidemic and strengthening public health.

2017 Key Topics

  • Strengthening Medicaid: Debating about the future of Medicaid expansion and many states are seeking responsible Medicaid reforms which would improve patient access and quality of care.
  • Reducing the U.S. opioid epidemic: Opioid-related legislation is said to focus mainly on mandated prescription drug monitoring program (PDMP), physician education, substance-use disorder treatment, and guidelines or restrictions on prescribing controlled substances.
  • Advancing physician-led team based care: Effort to establish a framework for physician-led team-based care.  Many States are moving away from fragmentation and more towards care coordination which will ensure that patients are provided the highest quality care at the lowest cost.
  • Provider network issues: Networks continue to narrow and patients’ financial responsibility for their health care continues to increase, the issues of network adequacy and out-of-network care.
  • Improving public health:  Several states, including Iowa, Indiana, South Dakota, Vermont and Washington, aim to join California and Hawaii in raising the minimum purchasing age for tobacco products to 21. Missouri will attempt to ban texting while driving and fight against a repeal of the state’s helmet laws. Also, State and National medical associations will be targeting a long list of additional issues such as diabetes prevention, decreasing cardiovascular disease, infectious disease prevention, obesity, student-athlete concussion, cardiac laws, women’s reproductive rights, tanning restrictions for minors and several others.

on

 

 

This program joins students with scientists and other experts to counteract the myths about drugs and alcohol that teens get from the internet, social media, TV,
movies, music, or from friends.

National Drug & Alcohol Facts week was launched in 2010 by scientists at the National Institute on Drug Abuse (NIDA).  NIDA created this in an effort to stimulate educational events in communities where teens could learn what science has taught us about drug use and addiction.

In 2016, the National Institute on Alcohol Abuse and Alcoholism became a partner and alcohol has been added as a topic area for the week. NIDA and NIAAA are part of the National Institutes of Health.

Here is some information from the 2016 Monitoring the Future (MTF) annual survey. 

This was a survey conducted of 8th, 10th, and 12th graders by researchers at the University of Michigan, Ann Arbor, under a grant from the National Institute on Drug Abuse, part of the National Institutes of Health.

As of 1975, the survey measured drug, alcohol, and cigarette use and related attitudes in 12th graders nationwide; 8th and 10th graders were incorporated into the survey in 1991.

2016 Highlights:

  • 45,4730 students participated from 372 public and private schools
  • 4 percent among 8th graders,
  • 8 percent among 10th graders, and
  • 3 percent among 12th graders.

Although these numbers may seem high, 2016’s survey results are encouraging.  These results illustrate that the past-year use of illicit drugs other than marijuana is continuing to decline to the lowest level in the history of the survey for all three grades.

These rates are down from peak rates of 12.6 percent for 8th graders in 1995, and 18.4 percent for 10th graders in 1996, and 21.6 percent for 12th graders in 2001.

Teen use of many substances is at its lowest level since the survey’s inception, regarding alcohol, cigarettes, heroin, cocaine, methamphetamines, inhalants, and sedatives (reported only by 12th graders).

Other illicit drugs surveyed also illustrated a 5-year decline.

  • marijuana (among 8th and 10th graders),
  • synthetic cannabinoids (K2/herbal incense, sometimes called “synthetic marijuana”),
  • prescription opioids (reported in the survey as “narcotics other than heroin”),
  • hallucinogens,
  • amphetamines, and
  • over-the-counter cough and cold medications

The survey also found a general decline in perceived risk of harm and disapproval of using several substances.

  • fewer 8th graders think that taking Ecstasy (MDMA) or synthetic cathinones (“bath salts”) occasionally is harmful,
  • fewer report disapproval of taking Ecstasy or inhalants regularly.
  • In 10th graders, there was a decrease in the percentage of students who perceive a risk of harm from the following:
    • trying inhalants or synthetic cathinones once or twice
    • taking Crack, Vicodin®, or synthetic cathinones occasionally
    • using inhalants regularly

Marijuana

Marijuana usage has declined amongst 8th and 10th graders and remains unchanged among 12th graders compared to 5 years ago, despite the changing state marijuana laws. Past-year use of marijuana is at its lowest level in more than 2 decades among 8th and 10th graders.

Last Year Results (8th Graders)

  • Daily use declined from 1.1% to 0.07%

Last 5 Years

  • Daily use decreased form 1.3% to 0.7% (8th Graders)
  • Daily use decreased from 3.6% to 2.5% (10th Graders)
  • 0% continue to report daily use (12 Graders)

Click here to test your knowledge https://teens.drugabuse.gov/quiz/national-drug-alcohol-facts-week/take-iq-challenge/2016

on

 

 

As the opioid epidemic continues to sweep throughout America, there is an ever-greater number of drug-dependent newborns being reported in rural areas which are straining hospital neonatal units and draining precious medical resources.

This problem has rapidly grown and shows no signs of reduction.  Researchers have reported and published their study in JAMA Pediatrics, which concludes that the increase in drug-dependent newborns has been disproportionately larger in rural areas.

From 2004 to 2013, the proportion of newborns born dependent on drugs increased nearly sevenfold in hospitals in rural counties, to 7.5 per 1,000 from 1.2 per 1,000. By contrast, the uptick among urban infants was nearly fourfold, to 4.8 per 1,000 from 1.4 per 1,000.  Researchers concluded that these rising rates are due largely to the widening use of opioids among pregnant women.

“The problem is accelerating in rural areas to a greater degree than in urban areas,” said Dr. Veeral Tolia, a neonatologist who works at Baylor University Medical Center in Dallas and was not involved in the new report.

Some neonatal intensive care units, called NICUs, now devote 10 percent of their hours to caring for infants who have withdrawal symptoms.

Hospitals in the eye of this storm are commonly under resourced, experts said.

Using data from 2012 and 2013, a recent federal study found states like West Virginia, Maine and Vermont had particularly high rates of what is known as neonatal abstinence syndrome. It includes such symptoms as irritability, breathing problems, seizures and difficulties taking a bottle or being breast-fed.

Babies may be born with symptoms of withdrawal from any number of drugs, including certain antidepressants or barbiturates, after prolonged use by their mothers during pregnancy. But the new report found that rates of infant drug dependency are rising in tandem with maternal opioid use in particular.

Doctors frequently prescribe opioids to mothers-to-be to treat back pain or abdominal pain. Nearly 42 percent of pregnant women in Utah on Medicaid were prescribed opioids, and roughly 35 percent in Idaho, a 2014 study found.

Maternal opioid use was nearly 70 percent higher in rural counties than urban ones, the new report found.

Last year, a study published in The New England Journal of Medicine found that neonatal intensive care units nationwide that used to spend less than 1 percent of their days caring for these infants now must devote 4 percent of their staff hours to the task.

For many, the logistics can be difficult. Methadone, a drug commonly used in treatment programs, must be distributed at a clinic every day, which is “very challenging if you’re talking about a rural community where there isn’t much local health care,” Dr. Tolia said.

Pregnant women may also be treated with buprenorphine, available at certain pharmacies. In theory, Dr. Tolia said, it could be more easily distributed to rural areas.

“Our solutions need to be focused on where the disease is happening in communities,” he said. Once a baby arrives in a neonatal intensive care unit, “it’s too late.”

In July, President Obama signed into law the Comprehensive Addiction and Recovery Act, or CARA. It stipulated that federal officials should give priority to funding programs in rural areas to improve treatment for pregnant women.

Accredited Drug Testing offers Limit of Detection testing which varies from the standard in toxicology testing is to utilize cut-off levels.  Limit of Detection means reporting any detectable amount of drug.  A test can be performed using Limit of Detection by contacting our corporate office at 800-221-4291.

on

 
Florida Medical MarijuanaMany Floridians are cheering because today is the day that Amendment 2 Is in effect. The future of medical marijuana became more optimistic when Amendment 2 was passed in November’s election.

On Tuesday Jan. 3, Florida’s newest constitutional amendment goes into effect which expands the scope of medical marijuana in the Sunshine State.

Amendment 2 has had a troubled history in the past with Florida and when it first was placed on the ballots in 2014 the opposition was fierce. The major opposition at that time was Drug Free Florida who ran an intense attack campaign against the measure and it failed.

In November, the opposition was much less and voters overwhelmingly backed the measure, approving it with 71 percent of the vote.  Amendment 2 is designed to expand the use of medical marijuana. As the Amendment currently reads, low-THC marijuana is only available to patients suffering from debilitating illnesses like cancer and epilepsy. Under the new regulations, those conditions will be expanded to include HIV/AIDS, Parkinson’s disease, glaucoma and other conditions licensed practitioners see as a debilitating illness.

Not every licensed physician will be licensed to prescribe medical marijuana. However, Doctors’ who want to prescribe the drug must complete an eight-hour course and an examination and patients must be under the doctor’s care for at least three months before they’re given the approval for medical marijuana.

Per the Florida Department of Health, there are only 340 physicians statewide currently registered to prescribe medical marijuana.

Dispensaries have been working tirelessly to ensure that they are ready for an influx of patients requesting the drug. In Florida, there have been seven organizations have been in discussions to dispose medical marijuana, but only five have been authorized to do so.

State lawmakers will also have to decide the future of regulating the drug once Amendment 2 is 100% in effect. Florida lawmakers are working on a time crunch and they will need to partner with the Florida Department of Health within a six-month time frame to revise the current dispensing rules as they stand.

Once they have been revised, they will have up to nine months to implement those rules, which could throw a snag into the dispensing of the state’s newest prescription drug.

For information regarding the effects of drug abuse – Click Here
For  information on a drug free work place – Click Here
For  information on substance abuse programs – Click Here
For information on DOT Drug / Alcohol Testing requirements – Click Here

John Burgos, CPC
Business Development Manager
https://accrediteddrugtesting.net
(800) 221-4291
Accredited Drug Testing

on

 

FMCSA Random Drug Testing FMCSA reduced the required drug testing rate in 2016 from 50% to the current 25% of random drug testing for all ‘Safety Sensitive” regulated employees following years of tests yielding positive results at less than 1 percent.

The decision to lower the rate was due to three consecutive calendar years (2011, 2012, 2013) of drug testing data received in FMCSA’s Management Information System (MIS) survey which showed a positive rate for controlled substances was less than one percent.

On December 13, 2016, The Federal Motor Carrier Safety Administration (FMCSA) announced that it will maintain its current 25 percent random drug testing rate of truck operators in 2017.

All motor carriers will be required to be actively enrolled in a DOT Consortium and be subject to random testing of 25 percent of their drivers in the calendar year. This regulation also includes single owner-operators or leased carriers.

FMCSA requires trucking and bus companies to conduct random drug and alcohol tests at the nationally stipulated percentage.

Per federal regulations, when the FMCSA receives data in their MIS for two consecutive calendar years and reveals that the positive rate for controlled substances is less than one percent, FMCSA has the discretion to lower the annual testing rate to a minimum of 25 percent of a carriers’ driver positions. However, if at any time the positive rate for controlled substances exceeds one percent threshold, the testing rate will automatically revert to the 50 percent benchmark.

The most recent survey data available from 2014 illustrates the estimated positive usage rate for drugs was 0.9 percent.  For 2012 and 2013 respectively, the estimated positive usage rate for drugs was estimated to be 0.6 percent and 0.7 percent. Although there was a slight increase from 2012 to 2014, the positivity rates were still below the 1 percent threshold.

The estimated violation rate for Breath Alcohol Testing for alcohol usage which reflects the percentage of drivers with a blood alcohol content of 0.04 or higher was 0.08 percent in 2014. For 2012 and 2013, the alcohol usage violation rates were 0.03 percent and 0.09 percent, respectively.

To stay up to date on DOT Regulations or to subscribe to our newsletter http://accrediteddrugtesting.net/contact

on

 

As 2016 comes to an end, we would like to take a look back on the year in drugs and drug policy. Some might say that It is a mixed bag, with some major victories for drug reform but also some major challenges, specifically around heroin and prescription opioids, and the threat of things taking a turn for the worse in the coming years.

Here are some of the biggest stories from the year on drugs.

1. Accredited Drug Testing Acquires American Drug Testing

Logo-final-1Accredited Drug Testing is pleased to announce the acquisition of American Drug Testing, Inc., a national drug and alcohol testing company, specializing in employment related testing and individuals needing a drug, alcohol or DNA test. Mr. James A. Greer will serve as President/CEO of American Drug Testing, Inc, in addition to continuing as President of Accredited Drug Testing. The company motto
of “Above The Rest, When You Need A Test” will be the companies nationwide branding focus. Check out the company video.

2. NBC news interviews Accredited Drug Testing President

Jim Greer NBC InterviewNBC news interviews Accredited Drug Testing President / CEO James Greer regarding Federal Drug Testing Regulations. I-Team: Popular Drug Test Used for Drivers, Pilots Doesn’t Screen for Abused Prescriptions. See the interview.

3. Company President Interviewed By National Enquirer On JonBenét Ramsey Case

Our Company President and DNA Expert James A Greer was interviewed by the National Enquirer Magazine which includes comments and a photograph regarding the JonBenét Ramsey murder case. Stay tuned for an update on this story in 2017

4. Marijuana Legalization Wins Big

The legalization of marijuana had some victories in California, Maine, Massachusetts, and Nevada, losing only in Arizona. The first states to do so were Colorado and Washington which led the way in 2012, and Alaska, Oregon and Washington, D.C., following in 2014. The question is, where does marijuana win next? We won’t see state legalization initiatives until 2018

5. Medical Marijuana Wins Big

Florida Voters Legalize Medical MarijuanaMedical marijuana is even more popular than legal weed, and it went four-for-four at the ballot box in November, adding Arkansas, Florida, Montana and North Dakota to the list of full-blown medical marijuana states. That makes 28 states—more than half the country—that allow medical marijuana, along with another dozen or so red states that have passed limited CBD-only medical marijuana laws as a sop to public opinion.

The increasing acceptance of medical marijuana is going to make it that much harder for the DEA or the Trump administration to balk at reclassifying marijuana away from Schedule I, which is supposedly reserved for dangerous substances with no medical uses. It may also, along with the growing number of legal pot states, provide the necessary impetus to changing federal banking laws to allow pot businesses to behave like normal businesses.

6. The Opioid Epidemic Continues

Just as the year comes to an end, the CDC announced that opioid overdose deaths last year had topped 33,000, and with 12,000 heroin overdoses, junk had overtaken gunplay as a leading cause of death.

Furthermore, prosecutors in states across the country have taken to charging those who sell opioids (prescription or otherwise) to people who die of overdose with murder, more intrusive and privacy-invading prescription monitoring programs have been established, and the tightening of the screws on opioid prescriptions is leaving some chronic pain sufferers in the lurch and leading others to seek out opioids on the black market. Read more on this story.

7. DEA Held Prescription Take Back Day

OCT 17 – (Washington, DC) – DEA set to repeat on one of its most popular community programs this weekend, National Prescription Drug Take Back Day.  On Saturday October 22 between 10 a.m. and 2 p.m. the public can dispose of their unused, unwanted prescription medications at one of 4,700 collection sites nationwide, operated by 3,800 local law enforcement agencies and other community partners.  The service is free of charge, no questions asked. Read more.

8. DEA Say’s “NO” To Marijuana

dea-says-no-to-marijuanaMarijuana activists who hoped the number of US states progressing towards the legalization of medical marijuana would soften the federal stance on the drug faced a setback Thursday as the Drug Enforcement Administration (DEA) announced that itwill keep marijuana illegal for any purpose. Read more.

9. Drug Testing Positive Results by Classification

Let’s take a more in-depth look at the statistics, facts, data, and outputs that have an impact workplace drug testing programs. Utilizing Quest Diagnostics as a resource, we will take a deeper dive into positivity by drug type. Read more.

10. FMCSA Establishes National Drug & Alcohol Testing Clearinghouse for Commercial Truck and Bus Drivers.

cdl-clearinghouseOn December 2, 2016, the U.S. Department of Transportation’s (DOT) Federal Motor Carrier Safety Administration (FMCSA) announced a final rule that would establish a National Drug and Alcohol Clearinghouse for commercial truck and bus drivers. Read more.

 

 

For information regarding the effects of drug abuse – Click Here
For  information on a drug free work place – Click Here
For  information on substance abuse programs – Click Here
For information on DOT Drug / Alcohol Testing requirements – Click Here

John Burgos, CPC
Business Development Manager
https://accrediteddrugtesting.net
(855)919-3784
Accredited Drug Testing

on

FMCSA Establishes National Drug and Alcohol Testing Clearinghouse for Commercial Truck and Bus Drivers

cdl-clearinghouseOn December 2, 2016, the U.S. Department of Transportation’s (DOT) Federal Motor Carrier Safety Administration (FMCSA) announced a final rule that would establish a National Drug and Alcohol Clearinghouse for commercial truck and bus drivers.

The clearinghouse database will serve as a central information warehouse that will contain records of violations of FMCSA’s Drug and Alcohol Testing Program (Part 40) which is required for commercial driver’s license (CDL) holders. The National Drug and Alcohol Clearinghouse Final Rule goes into effect in January 2020, which is three years after its effective date.

Once the clearinghouse database is established, motor carrier employers will be required to query the database for information regarding current or prospective employees who have unresolved violations of the Federal Drug and Alcohol Testing Regulations that prohibit them from operating a commercial motor vehicle (CMV).  The Final Clearinghouse Rule also requires employers and medical review officers (MRO) to report drug and alcohol testing program violations.

“This is a major safety win for the general public and the entire commercial motor vehicle industry,” said FMCSA Administrator Scott Darling.  “The clearinghouse will allow carriers across the country to identify current and prospective drivers who have tested positive for drugs or alcohol, and employ those who drive drug- and alcohol-free.  Drivers who test positive for drugs or alcohol will no longer be able to conceal those test results from employers and continue to drive while posing a safety risk to the driving public.”

The final rule requires motor carriers, medical review officers, third-party administrators, and substance abuse professionals to report information about drivers who:

  • Test positive for drugs or alcohol;
  • Refuse drug and alcohol testing; and
  • Undergo the return-to-duty drug and alcohol rehabilitation process.

Additionally, motor carriers will be required to annually search the clearinghouse for current employees, and during the pre-employment process for prospective employees, to determine whether a driver violated drug or alcohol testing requirements with a different employer that would prohibit them from operating a CMV.

 

Federal safety regulations require employers to conduct pre-employment drug testing and random drug and alcohol testing.  Motor carriers are prohibited from allowing employees to perform safety-sensitive functions, which include operating a CMV, if the employee tests positive on a DOT drug or alcohol test.

In accordance with the Privacy Act of 1974 (5 U.S.C. § 552a), a driver must grant consent before an employer can request access to that driver’s clearinghouse record and before FMCSA can release the driver’s clearinghouse record to an employer.   After registering with the clearinghouse a driver can review his or her information at no cost.

Congress directed FMCSA to establish a national drug and alcohol clearinghouse as mandated by the Moving Ahead for Progress in the 21st Century Act (MAP-21).

To learn more about the drug and alcohol clearinghouse, click on this link.

 

Read the full FMCSA press release.

John Burgos, CPC

Business Development Manager
https://www.AmericanrugTesting.com
(855)919-3784
American Drug Testing Inc

Read the full FMCSA press release.

on

DEA temporarily bans synthetic opioid ‘pink’ after 46 deaths

Dec 13 2016

DEA temporarily bans synthetic opioid 'pink' after 46 deaths

The U.S. Drug Enforcement Administration (DEA) said it had temporarily categorized a synthetic opioid nicknamed “pink” as a dangerous drug, after receiving at least 46 reports of deaths associated with its use.

There is a huge epidemic in the U.S. with regards to the abuse of opioids – a class of drugs that includes heroin and prescription painkillers.

The Centers for Disease Control and Prevention estimates that 78 Americans die every day from opioid overdose.

“Pink”, known to chemists as U-47700, comes from a strain of deadly synthetic opioids that are far more potent than heroin, and is usually imported to the United States mainly from China.  This drug gets its name from the pink-purple hue that comes from the way it is cut or processed.

The DEA said it had temporarily categorized U-47700 as a “Schedule 1” substance, effective Nov. 14, classifying it as a dangerous addictive drug with no medicinal use, placing it on par with heroin, cannabis and LSD.

https://s3.amazonaws.com/public-inspection.federalregister.gov/2016-27357.pdf

The classification of “Pink” as a schedule I will last for two years, with a possibility of a longer extension if the DEA requires more data to determine whether it should be permanently scheduled.

Reports indicate that of the 46 fatalities, 31 occurred in New York and 10 in North Carolina of cases reporting between Oct. 2015 and Sept. 2016.

www.dea.gov


For information regarding the effects of drug abuse – Click Here
For  information on a drug free work place – Click Here
For  information on substance abuse programs – Click Here
For information on DOT Drug / Alcohol Testing requirements – Click Here
 

John Burgos, CPC
Business Development Manager
https://accrediteddrugtesting.net
(800) 221-4291
Accredited Drug Testing Inc
Health Screening USA Inc